eXoZymes Inc. Common Stock
EXOZ
Closed
$7.08
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 32 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
Key stats
Open
$7.08
Volume
11.19K
Market cap
$65.71M
Prev. close
$7.08
Impl / hst vl
-
Open interest
$0.00
$7.08
Day’s Range
$7.08
$6.33
52W Range
$13.40
Valuation
16
Valuation score
Strongly Overvalued
P/E
-
P/S
-
P/B
45.86
Current ratio
1.32
Debt / Equity
-0.88
ROE
-220.64%
Gross margin
-
Income growth
-10.72%
FCF growth
-22.78
Analysts estimates
Earnings
Q1 ‘26 revenue
$0.00
Q1 ‘26 net income
-$2.37M
Revenue
Net income
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply